Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P140030/S021

Astron Peripheral Self- Expanding Nitinol Stent System

Biotronik AG · Decision date Oct 21, 2025

FDA DECISIONP140030/S021

What did the FDA approve?

FDA records P140030/S021 as a supplement to PMA P140030, with the supplement type “Special (Immediate Track)”. The recorded decision is approval, dated Oct 21, 2025.

FDA approval order statement

Approval to add a control step to verify the carton packaging material
Regulatory pathway
PMA supplement
Supplement type
Special (Immediate Track)
Clinical specialty
Cardiovascular
Decision date
Oct 21, 2025
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P140030/S021
Regulatory pathway
PMA supplement
Applicant
Biotronik AG
Product code
NIO
Decision code
APPR
Decision date
Oct 21, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: STENT, ILIAC.

Applicant
Biotronik AG
Product code
NIO
FDA device class
3

For the original device and its historical approval scope, see PMA P140030. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P140030 · Original PMA

    ASTRON PERIPHERAL SELF-EXPANDING NITINOL STENT SYSTEM

  2. P140030/S021 received

    Application receipt date recorded by FDA.

  3. P140030/S021 · FDA decision

    Special (Immediate Track)

  4. P140030/S024 · Related supplement

    Astron Peripheral Self-Expanding Nitinol Stent System

  5. P140030/S025 · Related supplement

    Astron Peripheral Self-Expanding Nitinol Stent System

Timeline entries are records held by MedtechLedger for P140030. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P140030

Product / regulatory recordCompanyPathwayDecision dateSource
Biotronik AGPMA approvalDec 17, 2015FDA
AstronP140030/S019
Biotronik AGPMA supplementJul 16, 2025FDA
AstronP140030/S022
Biotronik AGPMA supplementDec 17, 2025FDA
AstronP140030/S023
Biotronik AGPMA supplementMar 10, 2026FDA
Biotronik AGPMA supplementJun 22, 2026FDA
Biotronik AGPMA supplementSep 11, 2026FDA

Explore the linked device profile

Other records with product code NIO

Product / regulatory recordCompanyPathwayDecision dateSource
Cook Ireland, Ltd.PMA supplementNov 6, 2026FDA
Medtronic Vascular, Inc.PMA supplementOct 16, 2026FDA
Cordis US CorporationPMA supplementOct 15, 2026FDA
Boston Scientific CorpPMA supplementAug 21, 2026FDA
Boston Scientific CorpPMA supplementAug 6, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Biotronik AG

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Ackerstrasse 6, Bülach, 8180

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records